Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...
Aspire à mieux, the first ever vaping cessation program for young adults in Quebec
The Canadian Cancer Society (CCS) has officially launched Aspire à mieux, a program funded by the Ministère de la Santé et des Services sociaux du Québec. This vaping cessation program aims to address ...